D-Lactate and Glycerol As Potential Biomarkers of Sorafenib Activity in Hepatocellular Carcinoma

Scientists showed that sorafenib disrupts mitochondrial function by impairing the assembly of electron transport chain supercomplexes, thereby forcing cells to shift their metabolism toward glucose as the dominant energy source.